http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
고열을 동반한 혈액 및 혈액종양 환자의 세균감염에 대한 Ceftazidime(Fortum^(�))의 효과
박용선,김영철,김정일,최인선,박경옥 中央醫學社 1990 中央醫學 Vol.55 No.12
To assess the clinical efficacy of ceftazidime (Forturn�) for initial menagement of febrile patients with blood disease and hematologic malignancy, w ; conducted a trial using ceftazidime alone or combination with piperacillin and aminoglycoside in 24 patients during the last 8 months. The results were as follows. 1. We had "Cure" in 13 cases (54 %), "Improvement" in 6 cases (25 %), and "Failure" in 5 cases (19 %), namely, overall clinical response rate was 79 %. 2. Therapeutic response rates according to inital granulocyte count were 92 %, and 64 % in patients above and below 500/mm3 respectively. 3. There were no differences in response rates according to underlying diseases and sites of infection. 4. In MDI, response rate (100 %) was superior to that of CDI (71 %), possibly due to early addition of sensitive antibiotics. 5. Only in 2 cases, mild nausea was noted after N injection and, no deterioration of liver and renal function was demonstrated. These results indicated that ceftazidime, alone or combination with other drugs, could be suitable as an initial drug in febrile patients with blood disease and hematologic malignancy without notable side effects.